chr11-128838449-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_153766.3(KCNJ1):c.*676A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 152,368 control chromosomes in the GnomAD database, including 2,050 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2049 hom., cov: 32)
Exomes 𝑓: 0.090 ( 1 hom. )
Consequence
KCNJ1
NM_153766.3 3_prime_UTR
NM_153766.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0160
Genes affected
KCNJ1 (HGNC:6255): (potassium inwardly rectifying channel subfamily J member 1) Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. It is activated by internal ATP and probably plays an important role in potassium homeostasis. The encoded protein has a greater tendency to allow potassium to flow into a cell rather than out of a cell. Mutations in this gene have been associated with antenatal Bartter syndrome, which is characterized by salt wasting, hypokalemic alkalosis, hypercalciuria, and low blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 11-128838449-T-C is Benign according to our data. Variant chr11-128838449-T-C is described in ClinVar as [Benign]. Clinvar id is 303556.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.29 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNJ1 | NM_153766.3 | c.*676A>G | 3_prime_UTR_variant | 3/3 | ENST00000392666.6 | NP_722450.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNJ1 | ENST00000392666 | c.*676A>G | 3_prime_UTR_variant | 3/3 | 1 | NM_153766.3 | ENSP00000376434.1 | |||
KCNJ1 | ENST00000324036 | c.*676A>G | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000316233.3 | ||||
KCNJ1 | ENST00000392665 | c.*676A>G | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000376433.2 | ||||
KCNJ1 | ENST00000440599 | c.*676A>G | 3_prime_UTR_variant | 3/3 | 1 | ENSP00000406320.2 |
Frequencies
GnomAD3 genomes AF: 0.161 AC: 24460AN: 152094Hom.: 2041 Cov.: 32
GnomAD3 genomes
AF:
AC:
24460
AN:
152094
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0897 AC: 14AN: 156Hom.: 1 Cov.: 0 AF XY: 0.0909 AC XY: 8AN XY: 88
GnomAD4 exome
AF:
AC:
14
AN:
156
Hom.:
Cov.:
0
AF XY:
AC XY:
8
AN XY:
88
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.161 AC: 24488AN: 152212Hom.: 2049 Cov.: 32 AF XY: 0.163 AC XY: 12163AN XY: 74408
GnomAD4 genome
AF:
AC:
24488
AN:
152212
Hom.:
Cov.:
32
AF XY:
AC XY:
12163
AN XY:
74408
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
654
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Antenatal Bartter syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at